Publication Cover
Stress
The International Journal on the Biology of Stress
Volume 11, 2008 - Issue 1
739
Views
51
CrossRef citations to date
0
Altmetric
Original

Chronic administration of an angiotensin II receptor antagonist resets the hypothalamic–pituitary–adrenal (HPA) axis and improves the affect of patients with diabetes mellitus type 2: Preliminary results

Research Report

, , , , , , , , & show all
Pages 62-72 | Received 09 Feb 2007, Accepted 28 May 2007, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mirna B. Marques, Antônio Ribeiro-Oliveira$suffix/text()$suffix/text(), Jonas Guimarães, Guilherme F. Nascimento, Allan P. Anjos, Walkiria W. Vilas-Boas, Robson A. S. Santos, Julia D. Thomas, Susana M. Igreja, Ashley B. Grossman, Blerina Kola & Márta Korbonits. (2012) Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker. Stress 15:5, pages 554-561.
Read now

Articles from other publishers (50)

Aline Silva de Miranda, Danielle S. Macedo, Natalia P. Rocha & Antonio L. Teixeira. (2024) Targeting the Renin-Angiotensin System (RAS) for Neuropsychiatric Disorders. Current Neuropharmacology 22:1, pages 107-122.
Crossref
Naif H. Ali, Hayder M. Al‐Kuraishy, Ali I. Al‐Gareeb, Ali K. Albuhadily, Rabab S. Hamad, Athanasios Alexiou, Marios Papadakis, Hebatallah M. Saad & Gaber El‐Saber Batiha. (2023) Role of brain renin–angiotensin system in depression: A new perspective. CNS Neuroscience & Therapeutics.
Crossref
Sonia Villapol, Zachary C. Janatpour, Kwame O. Affram & Aviva J. Symes. (2023) The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury. Neurotherapeutics 20:6, pages 1565-1591.
Crossref
Sizhu Gong & Fang Deng. (2023) Renin-angiotensin system: The underlying mechanisms and promising therapeutical target for depression and anxiety. Frontiers in Immunology 13.
Crossref
Sheng-Chiang Wang, Jennifer S. Yokoyama, Nian-Sheng Tzeng, Chia-Fen Tsai & Mu-N Liu. 2023.
Zohreh Taghadosi, Asadollah Zarifkar, Vahid Razban & Hadi Aligholi. (2022) The effect of chronic stress and its preconditioning on spatial memory as well as hippocampal LRP1 and RAGE expression in a streptozotocin-induced rat model of Alzheimer’s disease. Metabolic Brain Disease 37:8, pages 2699-2710.
Crossref
Thomas T van Sloten, Patrick C Souverein, Coen DA Stehouwer & Johanna HM Driessen. (2022) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension. Journal of Psychopharmacology 36:5, pages 594-603.
Crossref
L. Balthazar, Y.V.M. Lages, V.C. Romano, J. Landeira-Fernandez & T.E. Krahe. (2021) The association between the renin-angiotensin system and the hypothalamic-pituitary-adrenal axis in anxiety disorders: A systematic review of animal studies. Psychoneuroendocrinology 132, pages 105354.
Crossref
Marsal Sanches & Antonio Lucio Teixeira. (2021) The renin-angiotensin system, mood, and suicide: Are there associations?. World Journal of Psychiatry 11:9, pages 581-588.
Crossref
Elisabeth M. Balint, Marc N. Jarczok, Dominik Langgartner, Stefan O. Reber, Simon Endes, Arno Schmidt-Trucksäss, Alexandra Funk, Julia Klinghammer, Susanne Campbell, Harald Gündel & Christiane Waller. (2021) Heightened Stress Reactivity in Response to an Attachment Related Stressor in Patients With Medically Treated Primary Hypertension. Frontiers in Psychiatry 12.
Crossref
George S. Alexopoulos. (2021) Mechanisms and Treatment of Late-Life Depression. FOCUS 19:3, pages 340-354.
Crossref
Daria Słomińska, Katarzyna Manikowska, Marta Hoszman, Przemysław Łukasz Mikołajczak & Hanna Winiarska. (2021) Influence of selected drugs used in the treatment of type 2 diabetes and cardiovascular diseases on depressive disorders in elderly patients. Pharmacotherapy in Psychiatry and Neurology 37:1, pages 63-74.
Crossref
Rafaela Costa, Maeline Santos Morais Carvalho, Juliana Dinéia Perez Brandão, Roseli Peres Moreira, Tatiana Sousa Cunha, Dulce Elena Casarini & Fernanda Klein Marcondes. (2021) Modulatory action of environmental enrichment on hormonal and behavioral responses induced by chronic stress in rats: Hypothalamic renin-angiotensin system components. Behavioural Brain Research 397, pages 112928.
Crossref
Lilla Lenart & Andrea Fekete. 2021. The Neuroscience of Depression. The Neuroscience of Depression 283 292 .
Harald Murck, Lisa Lehr, Johannes Hahn, Matthias C. Braunisch, Daniela Jezova & Maxim Zavorotnyy. (2020) Adjunct Therapy With Glycyrrhiza Glabra Rapidly Improves Outcome in Depression—A Pilot Study to Support 11-Beta-Hydroxysteroid Dehydrogenase Type 2 Inhibition as a New Target. Frontiers in Psychiatry 11.
Crossref
Sophocles Chrissobolis, Anh N. Luu, Ryan A. Waldschmidt, Madison E. Yoakum & Manoranjan S. D'Souza. (2020) Targeting the renin angiotensin system for the treatment of anxiety and depression. Pharmacology Biochemistry and Behavior 199, pages 173063.
Crossref
Dora B. Balogh, Agnes Molnar, Adam Hosszu, Tamas Lakat, Judit Hodrea, Attila J. Szabo, Lilla Lenart & Andrea Fekete. (2020) Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition. Psychoneuroendocrinology 118, pages 104705.
Crossref
Y.Y. Cao, X. Xiang, J. Song, Y.H. Tian, M.Y. Wang, X.W. Wang, M. Li, Z. Huang, Y. Wu, T. Wu, Y.Q. Wu & Y.H. Hu. (2019) Distinct effects of antihypertensives on depression in the real-world setting: A retrospective cohort study. Journal of Affective Disorders 259, pages 386-391.
Crossref
Kwok H.C. Choy, Carolina A. Chavez, Jing Yu & Dmitry N. Mayorov. (2019) The effect of angiotensin AT1A inactivation on innate and learned fear responses in mice and its relationship to blood pressure. Psychoneuroendocrinology 107, pages 208-216.
Crossref
Baojian Xue, Yang Yu, Shun-Guang Wei, Terry G Beltz, Fang Guo, Robert B Felder & Alan Kim Johnson. (2019) Stress-Induced Sensitization of Angiotensin II Hypertension Is Reversed by Blockade of Angiotensin-Converting Enzyme or Tumor Necrosis Factor-α. American Journal of Hypertension 32:9, pages 909-917.
Crossref
George S. Alexopoulos. (2019) Mechanisms and treatment of late-life depression. Translational Psychiatry 9:1.
Crossref
Lilla Lenart, Dora B. Balogh, Nikolett Lenart, Adrienn Barczi, Adam Hosszu, Tamas Farkas, Judit Hodrea, Attila J. Szabo, Krisztian Szigeti, Adam Denes & Andrea Fekete. (2019) Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling. Diabetologia 62:8, pages 1501-1513.
Crossref
Viktorija Gustaityte, Martina Winkler, Ines Stölting & Walter Raasch. (2019) Influence of AT1 blockers on obesity and stress-induced eating of cafeteria diet. Journal of Endocrinology 240:1, pages 65-79.
Crossref
Leif Østergaard, Martin Balslev Jørgensen & Gitte Moos Knudsen. (2018) Low on energy? An energy supply-demand perspective on stress and depression. Neuroscience & Biobehavioral Reviews 94, pages 248-270.
Crossref
Ahmed Abdelaal Ahmed Mahmoud, Mark Campbell & Margarita Blajeva. (2018) Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?. Case Reports in Anesthesiology 2018, pages 1-4.
Crossref
Lei A. Wang, Annette D. de Kloet, Michael D. Smeltzer, Karlena M. Cahill, Helmut Hiller, Erin B. Bruce, David J. Pioquinto, Jacob A. Ludin, Michael J. Katovich, Mohan K. Raizada & Eric G. Krause. (2018) Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice. Neuropharmacology 133, pages 85-93.
Crossref
Dilys Lam, Marie-Laure Ancelin, Karen Ritchie, Richard Saffery & Joanne Ryan. (2018) DNA methylation and genetic variation of the angiotensin converting enzyme (ACE) in depression. Psychoneuroendocrinology 88, pages 1-8.
Crossref
João Vian, Círia Pereira, Victor Chavarria, Cristiano Köhler, Brendon Stubbs, João Quevedo, Sung-Wan Kim, André F. Carvalho, Michael Berk & Brisa S. Fernandes. (2017) The renin–angiotensin system: a possible new target for depression. BMC Medicine 15:1.
Crossref
Martin Mildner, Helge Müller-Fielitz, Ines Stölting, Olaf Jöhren, Muscha Steckelings & Walter Raasch. (2017) Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic α-cell-dependent mechanism. Naunyn-Schmiedeberg's Archives of Pharmacology 390:5, pages 505-518.
Crossref
Urmila Aswar, Shilpa Chepurwar, Sumit Shintre & Manoj Aswar. (2017) Telmisartan attenuates diabetes induced depression in rats. Pharmacological Reports 69:2, pages 358-364.
Crossref
Annette D. de Kloet, Lei Wang, Soledad Pitra, Helmut Hiller, Justin A. Smith, Yalun Tan, Dani Nguyen, Karlena M. Cahill, Colin Sumners, Javier E. Stern & Eric G. Krause. (2017) A Unique “Angiotensin-Sensitive” Neuronal Population Coordinates Neuroendocrine, Cardiovascular, and Behavioral Responses to Stress. The Journal of Neuroscience 37:13, pages 3478-3490.
Crossref
Harald Murck. 2017. Hormones, Brain and Behavior. Hormones, Brain and Behavior 159 179 .
D. Wincewicz, A. Juchniewicz, N. Waszkiewicz & J.J. Braszko. (2016) Angiotensin II type 1 receptor blockade by telmisartan prevents stress-induced impairment of memory via HPA axis deactivation and up-regulation of brain-derived neurotrophic factor gene expression. Pharmacology Biochemistry and Behavior 148, pages 108-118.
Crossref
Anjana Bali & Amteshwar Singh Jaggi. (2015) Differential role of angiotensin neuropeptides in repeated exposure of immobilization stress of varying duration in mice. Life Sciences 141, pages 90-98.
Crossref
Chevelle BrudeyJeanie ParkJan Wiaderkiewicz, Ihori Kobayashi, Thomas A. Mellman & Paul J. Marvar. (2015) Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 309:4, pages R315-R321.
Crossref
Aila J. Ahola, Valma Harjutsalo, Carol Forsblom & Per-Henrik Groop. (2014) Renin–angiotensin–aldosterone–blockade is associated with decreased use of antidepressant therapy in patients with type 1 diabetes and diabetic nephropathy. Acta Diabetologica 51:4, pages 529-533.
Crossref
M-L Ancelin, I Carrière, J Scali, K Ritchie, I Chaudieu & J Ryan. (2013) Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression. Translational Psychiatry 3:11, pages e322-e322.
Crossref
Ronnie Ramadan, Arshed A. Quyyumi, A. Maziar Zafari, Jose N. Binongo & David S. Sheps. (2013) Myocardial Ischemia and Angiotensin-Converting Enzyme Inhibition. Psychosomatic Medicine 75:9, pages 815-821.
Crossref
Juan M. Saavedra. (2012) Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders. Clinical Science 123:10, pages 567-590.
Crossref
Juan M. Saavedra. (2011) Angiotensin II AT1 Receptor Blockers Ameliorate Inflammatory Stress: A Beneficial Effect for the Treatment of Brain Disorders. Cellular and Molecular Neurobiology 32:5, pages 667-681.
Crossref
Enrique Sánchez-Lemus, Masaru Honda & Juan M. Saavedra. (2012) Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress. Behavioural Brain Research 232:1, pages 84-92.
Crossref
Anja Miesel, Helge Müller-Fielitz, Olaf Jöhren, Florian M Vogt & Walter Raasch. (2012) Double blockade of angiotensin II (AT1)-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats. British Journal of Pharmacology 165:8, pages 2721-2735.
Crossref
Helge Müller-Fielitz, Julia Landolt, Marc Heidbreder, Stefan Werth, Florian M. Vogt, Olaf Jöhren & Walter Raasch. (2012) Improved Insulin Sensitivity after Long-Term Treatment with AT1 Blockers Is Not Associated with PPARγ Target Gene Regulation. Endocrinology 153:3, pages 1103-1115.
Crossref
S. Häfner, J. Baumert, R.T. Emeny, M.E. Lacruz, M. Bidlingmaier, M. Reincke, H. Kuenzel, R. Holle, R. Rupprecht & K.H. Ladwig. (2012) To live alone and to be depressed, an alarming combination for the renin–angiotensin–aldosterone-system (RAAS). Psychoneuroendocrinology 37:2, pages 230-237.
Crossref
Luis H. Llano López, Fernando Caif, Sebastián García, Miriam Fraile, Adriana I. Landa, Gustavo Baiardi, José V. Lafuente, Jan J. Braszko, Claudia Bregonzio & Pascual A. Gargiulo. (2012) Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats. Pharmacological Reports 64:1, pages 54-63.
Crossref
Eric G. Krause, Annette D. de Kloet, Karen A. Scott, Jonathan N. Flak, Kenneth Jones, Michael D. Smeltzer, Yvonne M. Ulrich-Lai, Stephen C. Woods, Steven P. Wilson, Lawrence P. Reagan, James P. Herman & Randall R. Sakai. (2011) Blood-Borne Angiotensin II Acts in the Brain to Influence Behavioral and Endocrine Responses to Psychogenic Stress. The Journal of Neuroscience 31:42, pages 15009-15015.
Crossref
Maria G. Pavlatou, George Mastorakos, Alexandra Margeli, Evangelia Kouskouni, Nicholas Tentolouris, Nikos Katsilambros, George P. Chrousos & Ioannis Papassotiriou. (2011) Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation. European Journal of Clinical Investigation 41:6, pages 652-658.
Crossref
Kelly R. Conner, M. Elizabeth Forbes, Won Hee Lee, Yong Woo Lee & David R. Riddle. (2011) AT1 Receptor Antagonism Does Not Influence Early Radiation-Induced Changes in Microglial Activation or Neurogenesis in the Normal Rat Brain. Radiation Research 176:1, pages 71.
Crossref
Juan M. Saavedra, Enrique Sánchez-Lemus & Julius Benicky. (2011) Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology 36:1, pages 1-18.
Crossref
Omar S Al-Attas, Nasser M Al-Daghri, Majed S Alokail, Assim Alfadda, Ahmed Bamakhramah, Shaun Sabico, Dave Pritlove, Alison Harte, Gyanendra Tripathi, Philip G McTernan, Sudhesh Kumar & George Chrousos. (2010) Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. European Journal of Endocrinology 163:4, pages 601-607.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.